ATE298570T1 - Antibakterielle verbindungen - Google Patents

Antibakterielle verbindungen

Info

Publication number
ATE298570T1
ATE298570T1 AT01998040T AT01998040T ATE298570T1 AT E298570 T1 ATE298570 T1 AT E298570T1 AT 01998040 T AT01998040 T AT 01998040T AT 01998040 T AT01998040 T AT 01998040T AT E298570 T1 ATE298570 T1 AT E298570T1
Authority
AT
Austria
Prior art keywords
sub
alkyl
sup
antibacterial compounds
compounds
Prior art date
Application number
AT01998040T
Other languages
English (en)
Inventor
Mark A Seefeld
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE298570T1 publication Critical patent/ATE298570T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01998040T 2000-12-08 2001-12-07 Antibakterielle verbindungen ATE298570T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25427600P 2000-12-08 2000-12-08
PCT/US2001/048104 WO2002062339A1 (en) 2000-12-08 2001-12-07 Antibacterial compounds

Publications (1)

Publication Number Publication Date
ATE298570T1 true ATE298570T1 (de) 2005-07-15

Family

ID=22963638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01998040T ATE298570T1 (de) 2000-12-08 2001-12-07 Antibakterielle verbindungen

Country Status (7)

Country Link
US (1) US6987115B2 (de)
EP (1) EP1347759B1 (de)
JP (1) JP2004532816A (de)
AT (1) ATE298570T1 (de)
DE (1) DE60111774T2 (de)
ES (1) ES2241902T3 (de)
WO (1) WO2002062339A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03007142A (es) 2001-02-12 2004-05-24 Lilly Icos Llc Derivados de carbolina.
US7022856B2 (en) 2001-02-12 2006-04-04 Lilly Icos Llc. Carboline derivatives
ATE414082T1 (de) * 2003-04-29 2008-11-15 Oscient Pharmaceuticals Antibiotische tetrahydro-b-carbolinderivative
US7601840B2 (en) * 2004-03-15 2009-10-13 Ptc Therapeutics, Inc. Carboline derivatives useful in the inhibition of angiogenesis
US7364432B2 (en) * 2004-03-31 2008-04-29 Drb Lit Ltd. Methods of selecting Lock-In Training courses and sessions
EP1783128A1 (de) * 2005-11-07 2007-05-09 Eidgenössische Technische Hochschule Zürich Heterozyklische Verbindungen und deren Anwendung als Antifouling-Mittel
EP2225250A2 (de) 2007-11-30 2010-09-08 Biota Scientific Management Pty Ltd Bicyclische ppat-inhibitoren als antibakterielle mittel
WO2009102377A2 (en) * 2007-11-30 2009-08-20 Maxthera Inc. Antibiotic tetrahydro-beta-carboline derivatives
WO2010138644A1 (en) 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Processes for the preparation of substituted tetrahydro beta-carbolines
WO2010138652A1 (en) 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Methods for treating kaposi sarcoma
WO2010138685A1 (en) 2009-05-27 2010-12-02 Ptc Therapeutics, Inc. Methods for treating prostate conditions
HUE052510T2 (hu) 2009-05-27 2021-05-28 Ptc Therapeutics Inc Módszerek a rák és a nem daganatos állapotok kezelésére
TWI784255B (zh) 2014-12-18 2022-11-21 瑞士商赫孚孟拉羅股份公司 四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途
US20180002344A1 (en) 2016-06-16 2018-01-04 Genentech, Inc. Heteroaryl estrogen receptor modulators and uses thereof
US11458126B2 (en) 2017-08-01 2022-10-04 Ptc Therapeutics, Inc. DHODH inhibitor for use in treating hematologic cancers
LT3810283T (lt) 2018-06-21 2023-08-25 F. Hoffmann-La Roche Ag 3-((1r,3r)-1-(2,6-difluor-4-((1-(3-fluorpropil)azetidin-3- il)amino) fenil)-3-metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)- 2,2- difluorpropan-1-olio tartrato druskos kietosios formos, jų paruošimo procesas ir jų naudojimo būdai vėžiui gydyti
EP3836919A4 (de) * 2018-08-16 2022-05-18 Recreo Pharmaceuticals Inc. 1,3,4,9-tetrahydro-2h-pyrido[3,4-b]indol-derivatverbindungen und verwendungen davon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR024158A1 (es) 1999-06-01 2002-09-04 Smithkline Beecham Corp Compuestos antibacterianos
UA74826C2 (en) * 2000-05-17 2006-02-15 Ortho Mcneil Pharm Inc ?-carboline derivatives as phosphodiesterase inhibitors

Also Published As

Publication number Publication date
EP1347759B1 (de) 2005-06-29
ES2241902T3 (es) 2005-11-01
DE60111774T2 (de) 2006-05-04
DE60111774D1 (de) 2005-08-04
JP2004532816A (ja) 2004-10-28
EP1347759A1 (de) 2003-10-01
US20040053954A1 (en) 2004-03-18
WO2002062339A1 (en) 2002-08-15
EP1347759A4 (de) 2004-04-21
US6987115B2 (en) 2006-01-17

Similar Documents

Publication Publication Date Title
HK1045644A1 (zh) 抗菌化合物
DE60111774D1 (de) Antibakterielle verbindungen
BG106390A (en) Novel spiro compounds
NO996108L (no) 9-oksinerytromycinderivater
DK41193D0 (da) Ionkanalaabnere
IS6565A (is) Trópan afleiður nytsamlegar í meðferð
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
NZ544009A (en) Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
WO2001009103A3 (en) Imidazole antiproliferative agents
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
ATE398117T1 (de) Verbindungen mit antibakteriellen und antiparasitischen eigenschaften
SE0004245D0 (sv) Novel compounds and their use
PE20001297A1 (es) Antibioticos cetolidos carbamato y carbazato
MXPA03002911A (es) Compuestos quimicos.
AU2001266575A1 (en) Chemical compounds
AU1192501A (en) Fab i inhibitors
GB0021421D0 (en) Compounds
DE69505470D1 (de) Pyrrolocarbazol
WO2003053971A8 (en) Pyridoquinoxaline antivirals
CA2286511A1 (en) Novel macrolide derivatives
CA2316082A1 (en) Substituted 2-benzylamino-2-phenyl-acetamide compounds
WO2002032901A3 (en) Bridged piperazine derivatives
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
NZ515025A (en) Solvates of pymetrozine
AU5727899A (en) Diaminocyclobutene-3,4-dione derivatives, their preparation and use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties